ERGi-USU, a high affinity RIOK2 inhibitor, binds RIOK2 directly and induces a ribosomal stress signature, resulting in growth inhibition of ERG-positive VCaP tumor xenografts (Mohamed et al., 2018). The gene discussed is RIOK2; the disease is neoplasm.